Rhabdomyolysis and renal function impairment after isolated limb perfusion—Comparison between the effects of perfusion with rhTNFα and a ‘triple-drug’ regimen

This publication has 18 references indexed in Scilit:

• Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.
  Journal of Clinical Oncology, 1996
• A possible role for antibodies to tumour necrosis factor alpha and to endotoxin in the treatment of Reye's syndrome.
  Gut, 1995
• TNF-Stimulated Arginine Transport by Human Vascular Endothelium Requires Activation of Protein Kinase C
  Annals of Surgery, 1995
• Systemic and Hemodynamic Effects of Recombinant Tumor Necrosis Factor Alpha in Isolation Perfusion of the Limbs
  Chest, 1995
• Pharmacokinetics and results of dose escalation inCis-platin hyperthermic isolation limb perfusion
  Annals of Surgical Oncology, 1994
• Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan
  Cancer, 1994
• Isolated limb perfusion for melanoma: Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs
  World Journal of Surgery, 1992
• High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
  Journal of Clinical Oncology, 1992
• Isoforms of creatine kinase MM and MB in acute myocardial infarction: a clinical evaluation
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1986
• Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions
  European Journal of Cancer and Clinical Oncology, 1982